← EPO Patent Bulletin

USE OF TUMOR INFILTRATING LYMPHOCYTES FOR TREATING NSCLC PATIENTS REFRACTORY FOR ANTI-PD-1 ANTIBODY

Publication EP4378530A2 Kind: A2 Mar 18, 2026

Applicants

Iovance Biotherapeutics, Inc.

Inventors

FARDIS, Maria, NATARAJAN, Arvind

IPC Classifications

A61K 35/17 20150101AFI20240722BHEP A61K 45/06 20060101ALI20240722BHEP C12N 5/00 20060101ALI20240722BHEP A61P 35/00 20060101ALI20240722BHEP C12N 5/0781 20100101ALI20240722BHEP A61K 39/00 20060101ALI20240722BHEP C12N 5/0783 20100101ALI20240722BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR